Feasibility and safety of liver transplantation or resection after transarterial radioembolization with Yttrium-90 for unresectable hepatocellular carcinoma-Reference-Cited by-同舟云学术

Feasibility and safety of liver transplantation or resection after transarterial radioembolization with Yttrium-90 for unresectable hepatocellular carcinoma

Published:2019-11 Issue:11 Volume:21 Page:1497-1504
ISSN:1365-182X
Container-title:HPB
language:en
Short-container-title:HPB

Author:

Labgaa Ismail,Tabrizian Parissa,Titano Joseph,Kim Edward,Thung Swan N.,Florman Sander,Schwartz Myron,Melloul Emmanuel

Publisher

Elsevier BV

Subject

Gastroenterology,Hepatology

Reference24 articles.

1. Global cancer statistics, 2012;Torre;CA Cancer J Clin,2015

2. Annual report to the nation on the status of cancer, 1975–2014, featuring survival;Jemal;J Natl Cancer Inst,2017

3. Hepatocellular carcinoma;Llovet;Nat Rev Dis Primers,2016

4. Liver transplantation for the treatment of small hepatocellular carcinomas in patients with cirrhosis;Mazzaferro;N Engl J Med,1996

5. Management of hepatocellular carcinoma: an update;Bruix;Hepatology,2011

Cited by 28 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. hepatocellular carcinoma and liver transplantation;Liver Cancer - Multidisciplinary Approach;2024-07-22

2. Conversion therapy for initially unresectable hepatocellular carcinoma: Current status and prospects;BioScience Trends;2023-12-31

3. Contemporary applications of Y90 for the treatment of hepatocellular carcinoma;Hepatology Communications;2023-10

4. Preoperative transarterial chemoembolization (TACE) + liver resection versus upfront liver resection for large hepatocellular carcinoma (≥5 cm): a systematic review and meta-analysis;Acta Chirurgica Belgica;2023-09-08

5. Recent updates in the use of pharmacological therapies for downstaging in patients with hepatocellular carcinoma;Expert Opinion on Pharmacotherapy;2023-06-29